Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants: a prospective cohort study

Collapse authors list.
Parker, Edward ORCID: 0000-0001-5847-109X, Bronowski, Christina ORCID: 0000-0001-8089-4021, Sindhu, Kulandaipalayam Natarajan, Babji, Sudhir ORCID: 0000-0002-1288-374X, Benny, Blossom, Carmona-Vicente, Noelia, Chasweka, Nedson, Chinyama, End, Cunliffe, Nigel ORCID: 0000-0002-5449-4988, Dube, Queen et al (show 19 more authors) , Giri, Sidhartha, Grassly, Nicholas ORCID: 0000-0001-6067-4507, Gunasekaran, Annai, Howarth, Deborah, Immanuel, Sushil, Jere, Khuzwayo ORCID: 0000-0003-3376-8529, Kampmann, Beate, Lowe, Jenna, Mandolo, Jonathan, Praharaj, Ira ORCID: 0000-0002-0541-1146, Rani, Bakthavatsalam Sandya, Silas, Sophia, Srinivasan, Vivek Kumar, Turner, Mark ORCID: 0000-0002-5299-8656, Venugopal, Srinivasan, Verghese, Valsan Philip, Darby, Alistair ORCID: 0000-0002-3786-6209, Kang, Gagandeep and Iturriza-Gómara, Miren (2020) Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants: a prospective cohort study Nature Communications. 2020.11.02.20224576-. ISSN 2041-1723

Text ROVI_NCOMMS.pdf - Published version Download (2MB) | Preview

Abstract

Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries may lead to improvements in vaccine design and delivery. We measured maternal rotavirus antibodies, environmental enteric dysfunction (EED), and bacterial gut microbiota development among infants receiving two doses of Rotarix in India (n = 307), Malawi (n = 119), and the UK (n = 60), using standardised methods across cohorts. ORV shedding and seroconversion rates were significantly lower in Malawi and India than the UK. Maternal rotavirus-specific antibodies in serum and breastmilk were negatively correlated with ORV response in India and Malawi, and this was mediated partly by a reduction in ORV replication. In the UK, ORV replication was not inhibited despite comparable maternal antibody levels. In both India and Malawi, pre-vaccination microbiota diversity was negatively correlated with ORV immunogenicity, suggesting that high early-life microbial exposure may contribute to impaired vaccine efficacy.

Item Type:	Article
Uncontrolled Keywords:	3107 Microbiology, 31 Biological Sciences, 32 Biomedical and Clinical Sciences, Pediatric, Biotechnology, Immunization, Prevention, Vaccine Related, Women's Health, Infectious Diseases, Nutrition, Clinical Research, Digestive Diseases, Microbiome, Health Disparities, 2.2 Factors relating to the physical environment, Infection
Divisions:	Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences
Depositing User:	Symplectic Admin
Date Deposited:	11 Mar 2022 08:12
Last Modified:	01 Jan 2026 19:12
DOI:	10.1101/2020.11.02.20224576
Related Websites:	Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3150537
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.